Published in Heart on May 01, 2002
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ (2001) 6.32
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health (1985) 5.53
Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med (2001) 5.05
Access to coronary catheterisation: fair shares for all? BMJ (1993) 3.45
Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med (1996) 3.32
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation (1998) 2.40
Sex differences in cardiovascular disease: are women with low socioeconomic status at high risk? Br J Gen Pract (1999) 2.26
Comparing AMI mortality among hospitals in patients 65 years of age and older: evaluating methods of risk adjustment. Circulation (1999) 1.69
Women with angina pectoris receive less antiplatelet treatment than men. Br J Gen Pract (1999) 1.51
Sex and race differences in short-term prognosis after acute coronary heart disease events: the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J (1999) 1.04
Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science (1997) 3.32
Improving outcomes for young people with diabetes: use of new technology and a skills-based training approach is urgently needed. Diabet Med (2001) 2.35
Cardiac troponin T. Lancet (1993) 2.13
Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia (2001) 1.98
Does temporal artery biopsy influence the management of temporal arteritis? QJM (2005) 1.67
ABC of arterial and venous disease. Swollen lower limb-1: general assessment and deep vein thrombosis. BMJ (2000) 1.62
Cost of endovascular versus open surgical repair of abdominal aortic aneurysms. Aust N Z J Surg (2000) 1.58
Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. Virology (2000) 1.56
Corticosteroid treatment of asthma: now at the crossroads. Respir Med (1999) 1.49
Hepatic cirrhosis: a clinico-pathological review of 520 cases. J Clin Pathol (1973) 1.47
Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int J Cancer (1987) 1.47
Pericardial disease associated with Grave's thyrotoxicosis. QJM (2002) 1.41
Modifications to the hand-held Gene Gun: improvements for in vitro biolistic transfection of organotypic neuronal tissue. J Neurosci Methods (2001) 1.40
Patient-controlled oramorph--the future? Anaesthesia (2000) 1.39
An evaluation of a new analyser for inhaled nitric oxide administration. Anaesth Intensive Care (1998) 1.37
Tissue and isoform-selective activation of protein kinase C in insulin-resistant obese Zucker rats - effects of feeding. J Endocrinol (1999) 1.36
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study. Diabetes Obes Metab (2009) 1.31
The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol (1999) 1.29
Calcium/calmodulin-dependent phosphorylation and activation of human Cdc25-C at the G2/M phase transition in HeLa cells. J Biol Chem (1999) 1.28
Polymerase chain reaction analysis of defective human T-cell leukemia virus type I proviral genomes in leukemic cells of patients with adult T-cell leukemia. J Virol (1991) 1.19
Selective ablation of differentiated cells permits isolation of embryonic stem cell lines from murine embryos with a non-permissive genetic background. Nat Genet (1996) 1.15
Variability of diurnal changes in ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and normotensive subjects. Am J Hypertens (2000) 1.14
Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res (1993) 1.13
Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy. AIDS Behav (2015) 1.13
A reappraisal of 'analgesic hip'. Ann Rheum Dis (1986) 1.11
Balloon occlusion of the abdominal aorta during caesarean hysterectomy for placenta percreta. Anaesth Intensive Care (1995) 1.08
Thyroid storm in a young woman resulting in bilateral basal ganglia infarction. Postgrad Med J (1993) 1.07
Gay men who are not getting tested for HIV. AIDS Behav (2012) 1.04
Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation? Eur J Vasc Endovasc Surg (2004) 1.00
Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. Virology (2001) 1.00
Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro. Gynecol Oncol (1993) 1.00
Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass. Aliment Pharmacol Ther (2003) 0.96
Allelic loss and the progression of breast cancer. Cancer Res (1995) 0.96
The National WIC Evaluation: evaluation of the Special Supplemental Food Program for Women, Infants, and Children. V. Longitudinal study of pregnant women. Am J Clin Nutr (1988) 0.96
Compartment syndrome following total knee arthroplasty: a report of seven cases. J Bone Joint Surg Br (2006) 0.95
Expression of an engineered form of recombinant procollagen in mouse milk. Nat Biotechnol (1999) 0.95
The treatment of microsporidial diarrhoea with thalidomide. AIDS (1995) 0.94
Thalidomide: a novel therapy for microsporidiosis. Gastroenterology (1997) 0.93
Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene. Brain (1999) 0.92
Prediction of the antihypertensive response to enalapril. J Hypertens (1990) 0.92
Diabetes mellitus and thermoregulation. Can J Physiol Pharmacol (1987) 0.91
Use of fluoxetine to treat dominance aggression in dogs. J Am Vet Med Assoc (1996) 0.91
Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies. Diabet Med (2009) 0.90
Cloning of human preprotachykinin-I promoter and the role of cyclic adenosine 5'-monophosphate response elements in its expression by IL-1 and stem cell factor. J Immunol (2001) 0.90
Influence of yeast culture on ruminal microbial metabolism in continuous culture. J Dairy Sci (2002) 0.90
When to use insulin in the maturity onset diabetic. Postgrad Med J (1987) 0.89
Testosterone-mediated regulation of mouse renal cytochrome P-450 isoenzymes. Biochem J (1990) 0.89
Quantitative and qualitative comparison of DNA amplification by PCR with immunofluorescence staining for diagnosis of Pneumocystis carinii pneumonia. J Clin Pathol (1993) 0.89
Analysis of inbreeding depression in the first litter size of mice in a long-term selection experiment with respect to the age of the inbreeding. Heredity (Edinb) (2007) 0.89
Microvascular vasodilator response to acetylcholine is increased in women with pre-eclampsia. BJOG (2001) 0.89
ABC of arterial and venous disease. Non-invasive methods of arterial and venous assessment. BMJ (2000) 0.89
Protein kinase C isoforms in human airway smooth muscle cells: activation of PKC-zeta during proliferation. Am J Physiol (1999) 0.88
Distinct phenotype associated with a cryptic subtelomeric deletion of 19p13.3-pter. Am J Med Genet A (2005) 0.88
Cavitating pneumonia caused by Corynebacterium group JK. J Clin Microbiol (1988) 0.88
Dose-response clarification in early drug development. J Hypertens Suppl (1991) 0.88
Rosiglitazone and pulmonary oedema: an acute dose-dependent effect on human endothelial cell permeability. Diabetologia (2003) 0.87
Complete rupture of the distal semimembranosus complex in a professional athlete. Clin Orthop Relat Res (1997) 0.86
Crohn's disease and myasthenia gravis: a possible role for thymectomy. Gut (1994) 0.86
Chimeric erythropoietin-interferon gamma receptors reveal differences in functional architecture of intracellular domains for signal transduction. J Biol Chem (1997) 0.86
Successful embolization of persistent endoleak from a patent inferior mesenteric artery. J Endovasc Surg (1997) 0.85
Transgenic livestock as bioreactors: stable expression of human alpha-1-antitrypsin by a flock of sheep. Biotechnology (N Y) (1993) 0.85
Circadian arrhythmia: shiftwork, travel and health. J Soc Occup Med (1986) 0.85
Nicotinic acetylcholine receptors on basophils and mast cells. Anaesthesia (2006) 0.84
Synaptic vesicles studied by dynamic light scattering. Eur Phys J E Soft Matter (2011) 0.84
Occupational high-pressure injection injuries: pathogenesis and prevention. J Soc Occup Med (1983) 0.84
Tissue- and time-dependent effects of endothelin-1 on insulin-stimulated glucose uptake. Biochem Pharmacol (2001) 0.84
Pressor and subpressor doses of angiotensin II increase insulin sensitivity in NIDDM. Dissociation of metabolic and blood pressure effects. Diabetes (1994) 0.84
Salmonellosis associated with late rupture of an aortofemoral bypass graft. Br J Surg (1979) 0.84
Assessment of lower limb microcirculation: exploring the reproducibility and clinical application of laser Doppler techniques. Skin Pharmacol Physiol (2011) 0.83
The role of cilostazol in the treatment of intermittent claudication. Curr Med Res Opin (2004) 0.83
Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung. Br J Clin Pharmacol (2000) 0.83
Effects of metformin and oleic acid on adipocyte expression of resistin. Diabetes Obes Metab (2006) 0.83
Does the angiotensin-converting enzyme (ACE) gene polymorphism affect rate of abdominal aortic aneurysm expansion? Eur J Vasc Endovasc Surg (2002) 0.83
PAK4 kinase activity and somatic mutation promote carcinoma cell motility and influence inhibitor sensitivity. Oncogene (2012) 0.83
Induction of immunosuppressive B-lymphocytes with components of Candida albicans. Adv Exp Med Biol (1988) 0.83
Effects of posture and venous insufficiency on endothelial-dependent and -independent cutaneous vasodilation in the perimalleolar region. Eur J Vasc Endovasc Surg (2003) 0.82
The euglycaemic hyperinsulinaemic clamp: an evaluation of current methodology. Clin Exp Pharmacol Physiol (1997) 0.82
ABC of arterial and venous disease. Ulcerated lower limb. BMJ (2000) 0.82
Tissue- and isoform-specific effects of aging in rats on protein kinase C in insulin-sensitive tissues. Clin Sci (Lond) (1999) 0.82
Predictability of antihypertensive responsiveness and alpha-adrenoceptor antagonism during prazosin treatment. Clin Pharmacol Ther (1989) 0.82
Clinical uses of 113mIn and other short-lived radioisotopes. Br J Radiol (1969) 0.81
Effect of testing experience and profession on provider acceptability of rapid HIV testing after implementation in public sexual health clinics in Sydney. HIV Med (2015) 0.81
The influence of MRI on treatment decisions regarding knee injuries. Am J Knee Surg (1999) 0.81
Lactational performance of Quackenbush Swiss line 5 mice. J Anim Sci (2006) 0.81
Prediction of response to antihypertensive therapy with enalapril and nifedipine. J Hypertens Suppl (1989) 0.80
A multicentre study comparing two methods for serum free light chain analysis. Ann Clin Biochem (2013) 0.80
Medical therapy for intermittent claudication. Eur J Vasc Endovasc Surg (2007) 0.80
Ecological risk assessment of endocrine disruptors. Environ Health Perspect (2000) 0.80
Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with Type 2 diabetes in secondary failure: outcomes after 1 year. Diabet Med (2003) 0.80
Percutaneous endoscopic gastrostomy (PEG): change in practice since 1988. Clin Nutr (2002) 0.79
Liver dysfunction associated with gold therapy for rheumatoid arthritis. J Rheumatol (1983) 0.79
Exercise in hypertrophic cardiomyopathy is associated with sympatho-adrenal imbalance. Int J Cardiol (2006) 0.79
Pharmacokinetics of calcium antagonists. J Cardiovasc Pharmacol (1988) 0.79
Dietary ascorbic acid and resistance to experimental renal candidiasis. J Nutr (1983) 0.79
Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: a double-blind, placebo-controlled crossover trial. J Clin Endocrinol Metab (2000) 0.79
Diabetic pregnancy 1977-1990: have we reached a plateau? J R Coll Physicians Lond (1992) 0.79
Bonding of amalgam to tooth structure: tensile adhesion and microleakage tests. J Prosthet Dent (1988) 0.79